Mixed phenotype acute leukemia with t(11;19)(q23;p13.3)/ MLL-MLLT1(ENL), B/T-lymphoid type: A first case report

American Journal of Hematology

Volumn 85, Issue 6, 2010, Pages 451-454

  Naghashpour, Mojdeh ^a   Lancet, Jeffrey ^a   Moscinski, Lynn ^a   Zhang, Ling ^a  

^a H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BUSULFAN; CYCLOPHOSPHAMIDE; DEXAMETHASONE; DOXORUBICIN; FLUDARABINE; HEMOGLOBIN; MERCAPTOPURINE; THYMOCYTE ANTIBODY; VINCRISTINE;

ACUTE LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADULT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; B LYMPHOCYTE; BLOOD CELL COUNT; BONE MARROW BIOPSY; BRAIN METASTASIS; CANCER COMBINATION CHEMOTHERAPY; CASE REPORT; CHROMOSOME Q BAND; CHROMOSOME TRANSLOCATION 11; CONSERVATIVE TREATMENT; CYTOCHEMISTRY; CYTOGENETICS; DRUG MEGADOSE; FEVER; FLOW CYTOMETRY; FOLLOW UP; GENERAL CONDITION IMPROVEMENT; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; LETTER; LEUKOCYTE COUNT; MALE; NAUSEA; NEUTROPHIL COUNT; PATIENT ASSESSMENT; PHENOTYPE; PRIORITY JOURNAL; T LYMPHOCYTE; THROMBOCYTE COUNT; VOMITING;

ACUTE DISEASE; ADULT; ANTIGENS, CD; ANTIGENS, NEOPLASM; BONE MARROW; CELL LINEAGE; CHROMOSOMES, HUMAN, PAIR 11; CHROMOSOMES, HUMAN, PAIR 19; GENE REARRANGEMENT; HUMANS; IMMUNOPHENOTYPING; IN SITU HYBRIDIZATION, FLUORESCENCE; LEUKEMIA; MALE; MYELOID-LYMPHOID LEUKEMIA PROTEIN; NEOPLASM PROTEINS; NUCLEAR PROTEINS; ONCOGENE PROTEINS, FUSION; TRANSCRIPTION FACTORS; TRANSLOCATION, GENETIC;

EID: 77953033233     PISSN: 03618609     EISSN: 10968652     Source Type: Journal    
DOI: 10.1002/ajh.21703     Document Type: Letter

References (27)

1. Swerdlow SH, Campo E, Harris NL, et al., editors.WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. Lyon:IARC; 2008.
2. Matutes E, Morilla R, Farahat N, et al. Definition of acute biphenotypic leukemia. Haematologica 1997;82:64-66.
3. Carbonell F, Swansbury J, Min T, et al. Cytogenetic findings in acute biphenotypic leukaemia. Leukemia 1996;10:1283-1287. (Pubitemid 26261423)
4. Lee JH, Min YH, Chung CW, et al. Prognostic implications of the immunophenotype in biphenotypic acute leukemia. Leuk Lymphoma 2008;49:700-709.
5. Dimartino JF, Cleary ML. Mll rearrangements in haematological malignancies: Lessons from clinical and biological studies. Br J Haematol 1999;106: 614-626.
6. Daser A, Rabbitts TH. Extending the repertoire of the mixed-lineage leukemia gene MLL in leukemogenesis. Genes Dev 2004;18:965-974.
7. Bain BJ, Moorman AV, Johansson B, et al. Myelodysplastic syndromes associated with 11q23 abnormalities. European 11q23 Workshop participants. Leukemia 1998;12:834-839.
8. Harbott J, Mancini M, Verellen-Dumoulin C, et al. Hematological malignancies with a deletion of 11q23: Cytogenetic and clinical aspects. European 11q23 Workshop participants. Leukemia 1998;12:823-827.
9. Ferrando AA, Armstrong SA, Neuberg DS, et al. Gene expression signatures in MLL-rearranged T-lineage and B-precursor acute leukemias: Dominance of HOX dysregulation. Blood 2003;102:262-268.
10. Thirman MJ, Gill HJ, Burnett RC, et al. Rearrangement of the MLL gene in acute lymphoblastic and acute myeloid leukemias with 11q23 chromosomal translocations. N Engl J Med 1993;329:909-914.
11. Armstrong SA, Staunton JE, Silverman LB, et al. MLL translocations specify a distinct gene expression profile that distinguishes a unique leukemia. Nat Genet 2002;30:41-47.
12. Yeoh EJ, Ross ME, Shurtleff SA, et al. Classification, subtype discovery, and prediction of outcome in pediatric acute lymphoblastic leukemia by gene expression profiling. Cancer Cell 2002;1:133-143.
13. Meyer C, Schneider B, Jakob S, et al. The MLL recombinome of acute leukemias. Leukemia 2006;20:777-784.
14. Zeisig BB, Garcia-Cuellar MP, Winkler TH, Slany RK. The oncoprotein MLL-ENL disturbs hematopoietic lineage determination and transforms a biphenotypic lymphoid/myeloid cell. Oncogene 2003;22:1629-1637.
15. Corral J, Lavenir I, Impey H, Warren AJ, et al. An Mll-AF9 fusion gene made by homologous recombination causes acute leukemia in chimeric mice: A method to create fusion oncogenes. Cell 1996;85:853-861. (Pubitemid 26192136)
16. Dobson CL, Warren AJ, Pannell R, et al. The mll-AF9 gene fusion in mice controls myeloproliferation and specifies acute myeloid leukaemogenesis. EMBO J 1999;18:3564-3574. (Pubitemid 29308837)
17. Lavau C, Szilvassy SJ, Slany R, Cleary ML. Immortalization and leukemic transformation of a myelomonocytic precursor by retrovirally transduced HRX-ENL. EMBO J 1997;16:4226-4237. (Pubitemid 27298175)
18. Lavau C, Luo RT, Du C, Thirman MJ. Retrovirus-mediated gene transfer of MLL-ELL transforms primary myeloid progenitors and causes acute myeloid leukemias in mice. Proc Natl Acad Sci USA. 2000;97:10984-10989.
19. Slany RK, Lavau C, Cleary ML. The oncogenic capacity of HRX-ENL requires the transcriptional transactivation activity of ENL and the DNA binding motifs of HRX. Mol Cell Biol 1998;18:122-129. (Pubitemid 28021024)
20. Horton SJ, Grier DG, McGonigle GJ, et al. Continuous MLL-ENL expression is necessary to establish a "Hox Code" and maintain immortalization of hematopoietic progenitor cells. Cancer Res 2005;65:9245-9252.
21. Nutt SL, Heavey B, Rolink AG, Busslinger M. Commitment to the B-lymphoid lineage depends on the transcription factor Pax5. Nature 1999;401:556-562.
22. Nutt SL, Eberhard D, Horcher M, et al. Pax5 determines the identity of B cells from the beginning to the end of B-lymphopoiesis. Int Rev Immunol 2001;20:65-82. (Pubitemid 32500866)
23. Eberhard D, Jimenez G, Heavey B, Busslinger M. Transcriptional repression by Pax5 (BSAP) through interaction with corepressors of the Groucho family. EMBO J 2000;19:2292-2303. (Pubitemid 30259010)
24. Rolink AG, Nutt SL, Melchers F, Busslinger M. Long-term in vivo reconstitution of T-cell development by Pax5-deficient B-cell progenitors. Nature 1999;401:603-606.
25. Pui CH, Gaynon PS, Boyett JM, et al. Outcome of treatment in childhood acute lymphoblastic leukaemia with rearrangements of the 11q23 chromosomal region. Lancet 2002;359:1909-1915.
26. Pui CH, Chessells JM, Camitta B, et al. Clinical heterogeneity in childhood acute lymphoblastic leukemia with 11q23 rearrangements. Leukemia 2003;17:700-706.
27. Rubnitz JE, Camitta BM, Mahmoud H, et al. Childhood acute lymphoblastic leukemia with the MLL-ENL fusion and t(11;19)(q23;p13.3) translocation. J Clin Oncol 1999;17:191-196.